NYSE: MMSMaximus Inc Stock
$70.43-0.97 (-1.36%)
Updated Jun 11, 2025
MMS Price
$70.43
Fair Value Price
N/A
Market Cap
$3.97B
52 Week Low
$63.77
52 Week High
$93.97
P/E
13.92x
P/B
2.38x
P/S
0.72x
PEG
1.66x
Dividend Yield
0.85%
Revenue
$5.40B
Earnings
$300.02M
Gross Margin
23.6%
Operating Margin
9.16%
Profit Margin
5.6%
Debt to Equity
1.52
Operating Cash Flow
$326M
Beta
0.7
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MMS Overview
Maximus Incorporated provides business process services (BPS) to government health and human services programs. Its U.S. Services segment offers program administration, appeals and assessments, and related consulting services to U.S. state and local government programs. Maximus was incorporated in 1975 and is headquartered in Tysons, VA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MMS's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Business Service
Industry Rating
B
MMS
Ranked#3 of 32
Ranked#3 of 32
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.42 | A | |
| $9.19 | B | |
| $40.17 | B |
Be the first to know about important MMS news, forecast changes, insider trades & much more!
MMS News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MMS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MMS ($70.43) is trading above its intrinsic value of $41.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MMS is good value based on its earnings relative to its share price (13.92x), compared to the US market average (31.17x)
P/E vs Market Valuation
MMS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MMS due diligence checks available for Premium users.
Valuation
MMS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.92x
Industry
32.61x
Market
31.17x
MMS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MMS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MMS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.38x
Industry
5.21x
MMS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MMS price to earnings growth (PEG)
For valuing profitable companies with growth potential
MMS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MMS's financial health
Profit margin
Revenue
$1.4B
Net Income
$96.6M
Profit Margin
7.1%
MMS's Earnings (EBIT) of $494.02M... subscribe to Premium to read more.
Interest Coverage Financials
MMS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.2B
Liabilities
$2.5B
Debt to equity
1.52
MMS's short-term assets ($1.33B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MMS's long-term liabilities ($1.81B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MMS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MMS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$42.7M
Investing
-$19.4M
Financing
$8.9M
MMS's operating cash flow ($325.88M)... subscribe to Premium to read more.
Debt Coverage Financials
MMS vs Specialty Business Service Stocks
Maximus Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.